Seahorse Bioscience, a part of Agilent Technologies

📍 Lexington, United States👥 78 employees💰 Last funded Jul 2007
Biotechnology🌐 agilent.com
Website LinkedIn
Seahorse is the flagship brand of Agilent's Cell Analysis division. Seahorse's Extracellular Flux (XF) technology is the gold standard in cell-based metabolic assays. Scientists worldwide use XF Analyzers to understand the role of energy metabolism in obesity, diabetes, aging, cancer, immunology, cardiovascular function and drug safety. Seahorse is also the leader in cost effective custom crafted labware solutions for scientists and OEM's. With unparalleled design expertise, Seahorse's labware designers and mold craftsmen provide fast turn around for all custom labware requirements. A complete line of filtration plates, reagent reservoirs, and high throughput compound storage plates are available for lab automation and high-throughput screening needs.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Seahorse Bioscience, a part of Agilent Technologies?
Seahorse Bioscience, a part of Agilent Technologies has 2 investors on record on gritt.io.
When did Seahorse Bioscience, a part of Agilent Technologies last raise funding?
The most recent investment in Seahorse Bioscience, a part of Agilent Technologies recorded on gritt.io was in July 2007.
What industry is Seahorse Bioscience, a part of Agilent Technologies in?
Seahorse Bioscience, a part of Agilent Technologies operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Seahorse Bioscience, a part of Agilent Technologies based?
Seahorse Bioscience, a part of Agilent Technologies is headquartered in Lexington, United States.